In vitro work by Sikiric and collaborators shows BPC-157 upregulates VEGFR2 expression in endothelial cells, which stimulates angiogenesis, the growth of new blood vessels into healing tissue
SLU5000 SLU-PP-332 5000 mcg x 50 Original price was: A$269.00.A$239.00Current price is: A$239.00
Efficacy and Safety of BPC 157: Studies BPC 157 has garnered significant interest within the scientific community, prompting a range of studies to investigate its potential therapeutic effects
Its a tri-agonist targeting three separate receptor systems simultaneously: The GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors
Pharmacologic GLP-1 RAs are synthetic analogs designed to resist degradation by dipeptidyl peptidase-4 (DPP-4), thereby prolonging their half-life
Many have to be injected, though some can be taken by mouth